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Abstract
Background: Systematic reviews have shown that exercise therapy and spinal manipulation are both more
effective for low back pain (LBP) than no treatment at all. However, the effects are at best modest. To enhance the
clinical outcomes, recommendations are to improve the patient selection process, and to identify relevant
subgroups to guide clinical decision-making. One of the systems that has potentials to improve clinical decision-
making is a treatment-based classification system that is intended to identify those patients who are most likely to
respond to direction-specific exercises, manipulation, or stabilisation exercises.
Methods/Design: The primary aim of this randomised controlled trial will be to assess the effectiveness of a
classification-based system. A sample of 150 patients with subacute and chronic LBP who attend a private physical
therapy clinic for treatment will be recruited. At baseline, all participants will undergo a standard evaluation by
trained research physical therapists and will be classified into one of the following subgroups: direction-specific
exercises, manipulation, or stabilisation. The patient will not be informed about the results of the examination.
Patients will be randomly assigned to classification-based treatment or usual care according to the Dutch LBP
guidelines, and will complete questionnaires at baseline, and 8, 26, and 52 weeks after the start of the treatment.
The primary outcomes will be general perceived recovery, functional status, and pain intensity. Alongside this trial,
an economic evaluation of cost-effectiveness and cost-utility will be conducted from a societal perspective.
Discussion: The present study will contribute to our knowledge about the effectiveness and cost-effectiveness of
classification-based treatment in patients with LBP.
Trial registration: Trial registration number: NTR1176
Background
Low back pain (LBP) is a common condition. It has a
lifetime prevalence of over 70% in industrialised coun-
tries, and accounts for considerable healthcare and
socioeconomic costs [1,2]. It is often not possible to
make a specific diagnosis based on patho-anatomical
causes, and 85-95% of the cases are diagnosed as “non
specific” LBP [3]. The lack of a clear patho-anatomical
basis for LBP has resulted in a large variation in LBP
diagnoses, and a multitude of poorly studied interven-
tions [4]. It has been assumed that randomised con-
trolled trials (RCTs) could provide answers to questions
such as ‘which intervention is most effective for which
patient’, but after the publication of more than 1,000
RCTs focusing on LBP, there is still a lack of evidence
regarding the most effective strategies for matching indi-
vidual patients to specific interventions. The Cochrane
Back Review Group acknowledged the limited role of
RCTs in providing useful information on aspects of LBP
management other than efficacy and effectiveness, and
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stated that additional etiological, diagnostic, and prog-
nostic studies are needed to identify varieties of LBP,
natural courses, or more homogeneous subgroups of
patients with LBP [5]. The identification of homogenous
subgroups according to evidence-based classification
systems was determined as a priority for primary care
research on LBP as early as 1996 [6].
Over the years, many attempts have been made to
classify patients with LBP into more homogeneous sub-
groups, based on the specific interventions that they are
likely to respond to. In 2007, Billis et al. identified 39
diagnostic and treatment-based classification systems
[7]. Most of the classification systems were based on
biomedical patient characteristics, and seldom on psy-
chosocial or biopsychosocial features. The majority of
the classification systems was based on a judgemental
approach, relying on clinical experience and intuition,
and a minority was based on a statistical approach and
prospective study designs.
One of the few classification systems that has poten-
tials to improve outcomes is a treatment-based classifi-
cation approach, originally proposed by Delitto et al.
[8]. This approach is based on the patient’s history, clin-
ical presentation, and a physical examination. It identi-
fies subgroups of patients who are most likely to
respond to the following interventions: (1) direction-
specific exercises, (2) manipulation, (3) stabilisation, and
(4) traction. Since the early nineties, several derivation
and validation studies have focused on these four inter-
ventions and the entire classification system (Additional
file 1) [9-20]. Two studies have investigated the validity
of the entire classification system, but because the stu-
dies used different RCT designs, they answered different
research questions. Fritz et al. [12] investigated the
effectiveness of the overall treatment approach of the
classification system (classification decision-making and
treatment protocols), whereas Brennan et al. [18]
focused on the effectiveness of the classification deci-
sion-making. In a RCT, Fritz et al. [12] compared treat-
ment according to the classification system with
treatment according to the clinical guidelines (low-stress
aerobic exercises and advice to remain active) for 78
patients with acute, work-related LBP. They found sta-
tistically significant better results for the outcomes of
disability and return to work in patients who were
receiving classification-based treatment at the four-week
follow-up, but not at the one-year follow-up. Their
research addressed the efficacy of the overall treatment
approach of the classification system. However, the
results may have been influenced by the treatment pro-
tocols that were used, and not the classification deci-
sion-making process. Brennan et al. [18] classified 123
patients with a duration of LBP of less than 90 days
according to the classification system. All patients were
randomised to receive direction-specific exercises,
manipulation or stabilisation, regardless their classifica-
tion. Outcomes were compared between patients who
had received ‘matched treatment’ (according to the clas-
sification) and ‘unmatched’ (non-classification) treat-
ment. The authors found a statistically significant
reduction in disability, favouring the matched treatment
group after 4 and 52 weeks.
The reliability of the classification system has been
assessed in four studies. In a study of 43 patients with
acute LBP, Fritz et al. [21] investigated the inter-rater
reliability of the classification of patients into one of the
subgroups by 7 physical therapists (PTs) who were
familiar with the system. They achieved a kappa value of
0.49. Kiesel et al. [22] achieved a slightly higher kappa
value (0.65) with 8 PTs who were familiar with the clas-
sification system and 30 patients with LBP. Heiss et al.
[23], in a study in which 45 acute LBP patients were
classified by four PTs who were unfamiliar with the
classification system, found a low kappa value (0.15).
Finally, Fritz et al. [24] investigated the inter-rater relia-
bility of the system in a vignette study with 30 PTs and
123 LBP patients, and reported a kappa value of 0.60.
These findings therefore provide preliminary evidence
that PTs who are familiar with the classification system
can obtain an acceptable level of intra-rater reliability.
It is essential for a treatment-based classification
approach to be dynamic, and to incorporate new evi-
dence. Since the original proposal, made by Delitto and
colleagues, the criteria for allocating a patient to a speci-
fic intervention, and also the intervention procedures,
have been revised and updated. However, although this
continued evolution of a classification system is neces-
sary in order to incorporate emerging evidence, it does
reduce the comparability of studies using different ver-
sions of the treatment-based classification approach, and
should motivate continued research on the approach.
In summary, the classification system proposed by
Delitto and colleagues [8] has evolved considerably, and
some promising results have been reported. However,
the evidence for its clinical usefulness is still limited.
Therefore, the aim of the present study is to evaluate
the cost-effectiveness of classification-based treatment,
compared to usual care according to national clinical
guidelines, in patients with subacute and chronic LBP in
primary care in the Netherlands. The present study will
focus on a revised version of the Delitto et al. treat-
ment-based classification system [8], based on updated
evidence outlined in previous RCTs [25], but is consis-
tent with the concept that sub-groups of patients can be
identified, and that the primary subgroups are patients
who are likely to respond to direction-specific exercises,
stabilisation or manipulation. The aim of this paper is to
describe the rationale and design of the study.
Apeldoorn et al. BMC Musculoskeletal Disorders 2010, 11:58
http://www.biomedcentral.com/1471-2474/11/58
Page 2 of 12
Methods/Design
Design
A randomised controlled trial will be conducted,
together with a full economic evaluation. Figure 1 pro-
vides an overview of the study design.
Setting
Up to 300 private physical therapy clinics, with more
than 1,000 PTs in the city of Amsterdam and the sur-
rounding (rural) area (< 50-kilometre radius), will be
invited to participate.
Ethical approval
In February 2008, the Medical Ethics Committee of the
VU University Medical Centre in Amsterdam approved
the study protocol (registration number: 2008\5).
Study population
The study population will consist of patients who seek
care in a participating private physical therapy clinic. The
inclusion criteria will be: LBP as primary complaint, with
or without associated leg pain, age between 18 and 65
years, current episode >6 weeks, able to speak and under-
stand Dutch, and willing to give written informed
consent. The exclusion criteria will be: known or sus-
pected specific LBP (e.g. cauda equina compression, frac-
tures), severe radiculopathy, spondylolisthesis (grade 2 or
more), serious co-morbidity, serious psychopathology,
lumbar spinal surgery in the previous year, more than
one low back operation, more than one year of absence
from work due to LBP, pregnancy or given birth in the
past three months, inability to attend 6 or more regular
physical therapy appointments, moderate complaints
about one or more items of the Urogenital Distress
Inventory (UDI 6, short form) or inability to demonstrate
any LBP symptoms during mechanical examination.
Recruitment of patients
PTs will inform all eligible LBP patients who attend
their clinic about the study. Subsequently, the principal
investigator (AA) will phone potentially eligible patients
to explain the trial procedures in detail and to check the
selection criteria. If a patient fulfils the initial require-
ments for eligibility, an appointment will be made at the
private physical therapy clinic that the patient attended,
where the patient will be asked to sign an informed con-
sent form and to complete baseline questionnaires. The
patient will then undergo a physical examination.
Figure 1 Design of the study.
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The PTs will also be asked to collect basic data from
eligible patients who are not willing to participate, and
to record their reasons for declining.
Research physical therapists
All patients will be examined by one of four research
PTs, all of whom have followed a post-graduate course
in manipulation and mobilisation techniques, and are
certified manual therapists (MTs) in the Netherlands.
Two research PTs have a Mechanical Diagnosis and
Therapy certificate (MDT or McKenzie method). The
two research PTs with no MDT certificate attended a
one-day MDT training session supervised by a senior
educator of the MDT Institute (HvH) to familiarise
them with the MDT system. Prior to the study, the
research PTs held meetings to standardise the examina-
tion protocol, to train in examination techniques and to
examine patients together. The research PTs will exam-
ine and classify the patients, but will not be involved in
providing the intervention.
Classification system
The classification system that will be used in this study
is a revised version of the system used by Brennan et al.
[18]. The classification system is a decision-making pro-
cedure that is used to allocate patients to one of the fol-
lowing treatment categories: direction-specific exercises,
manipulation, or stabilisation (Figure 2).
Baseline examination
The examination procedure will start with a standar-
dised history-taking, which will include questions on the
frequency of episodes, current duration, intensity, and
location of the symptoms. Subsequently, a standardised
comprehensive physical assessment will be made,
together with a neurological examination if indicated.
The examination starts with the determination of a
directional preference, based on the definition proposed
in the MDT classification method (step 1 in Figure 2)
[26]. This involves the monitoring of symptomatic and
mechanical responses during repetitive end-range lum-
bar test movements (flexion, extension, side-gliding, or
rotation) and/or prolonged positioning. A directional
preference is established if certain postures or repeated
end-range movements in one direction (e.g. flexion)
cause the symptoms to improve or centralise (pain
moves from a distal to a proximal area), and in the
opposite direction (e.g. extension) cause the symptoms
to worsen or peripheralise (pain moves from a proximal
to a distal area). Priority is given to peripheral pain loca-
tions and their response, regardless of the response of
the central pain intensity. The improved or centralised
symptoms must be retained in a neutral standing posi-
tion. A directional preference is not established if the
symptoms and the pain immediately reappear. For the
sake of clarity, patients with a directional preference do
not necessarily have centralisation of the symptoms.
After this assessment, several other physical tests, such
as the prone instability test, thigh thrust test, and the
active straight leg raise test will be performed (step 2 in
Figure 2). The operational definitions of these tests are
summarised in the Appendix (Additional file 2). The
classification decision-making has a hierarchical struc-
ture, however, all patients will undergo the entire exami-
nation procedure. In cases of uncertainty about the
primary classification, extra criteria, such as three or
more prior LBP episodes in the medical history and a
visible lateral shift during the examination, will be used
to determine the patient’s subgroup (step 3 in Figure 2).
Directly after this examination the research PT will
determine the patient’s classification and the level of
firmness of the conclusion: level 1. there is an obvious
primary classification; level 2. two of the three classifica-
tions are plausible; and level 3. none or all of the three
classifications are plausible. The patient will not be
informed about the results of the examination. Reasons
for exclusion, such as inability to demonstrate any LBP
symptoms during the examination, will be registered. It
is the intention that the principal investigator (AA) will
examine all patients. To identify patients reliably, one of
the three other research PTs, depending on availability,
will attend the examination procedure. When two
research PTs examine a patient, the primary classifica-
tion will be reached by consensus.
Treatment allocation
To conceal the treatment allocation, an independent
researcher who is not involved in the selection of the
patients will randomise each patient to one of the two
treatment groups. Randomisation lists will be generated
by computer before the study starts, pre-stratified for
the duration of the complaints (6-12 weeks or >12
weeks) and disability (Oswestry Disability Index [ODI]
<25% or ≥25%) to prevent unequal distribution. To pre-
vent unequal treatment-group sizes, the patients will be
randomised according to a stratified block randomisa-
tion method, in blocks of four. No treatment will be
given prior to randomisation.
Directly after the randomisation procedure, the PT
who will provide treatment will be informed about the
group allocation. Patients will be scheduled for their
first treatment session as soon as possible in the private
practice they attended.
Physical therapists in the participating clinics
All patients will be treated by PTs in the participating
clinics. In each clinic, at least one PT will be instructed
about the classification system, and at least one PT will
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be instructed about the usual care procedure, depending
on preference and expertise. PTs who will provide
manipulation treatment must be licensed, post-graduate
MTs or in the 4th and final year of the MT master edu-
cation program at the Educational Center for Musculos-
keletal Therapies (SOMT) in the Netherlands. No extra
qualifications will be required to treat patients according
to the classifications of direction-specific exercises and
stabilisation. The number of years of experience of the
PTs, and their post-graduate education in MT and/or
MDT, will be recorded for both treatment groups. To
minimise contamination, the PTs who will provide the
classification-based treatment will not be allowed to
provide usual care, and vice versa.
The PTs who will provide the classification-based
treatment will follow a five-hour training session in
Figure 2 Modified treatment-based classification system for patients with LBP (>6 weeks) as used in this RCT.
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which the treatment protocols will be described and dis-
cussed. Experts on direction-specific exercises (HvH)
and stabilisation will provide the training. The PTs will
receive a detailed manual of the study, and a translation
of the registration forms and treatment protocols used
in the Brennan et al. study [18]. The PTs providing
usual care will receive a two-hour training course in the
rationale and treatment components described in the
LBP guidelines issued by the Royal Dutch College for
Physical Therapy (KNGF) [27,28].
Intervention according to the Dutch LBP guidelines
Patients assigned to usual care will receive PT or MT
according to the current Dutch LBP guidelines [27,28].
The PTs providing usual care will not be informed
about the physical examination and classification proce-
dure, and will therefore reassess the patient to obtain
the relevant information for treatment. However, to
avoid inconvenience for the patient, and to increase the
chance that the patient remains unaware of the treat-
ment allocation, the PT will receive a written descrip-
tion of the patient’s medical history from the research
PTs. The patients will receive supervised, individually
tailored treatment based on their clinical presentation.
Treatment techniques vary within and among PTs, and
depend on the preferences and expertise of the PTs.
The focus of the treatment will be on improving func-
tion and participation. Interventions that are commonly
used in Dutch primary care are ‘hands-on’ muscular
mobilisation techniques, specific articular mobilisation
and manipulation techniques, strength and stability
exercises, massage, and cognitive, respondent and oper-
ant techniques, such as relaxation exercises and graded
activity programmes. Decisions about the frequency and
the number of sessions are left to the discretion of the
PT. The number of treatment sessions, the treatment
modalities, the treatment goals, any deviations from the
protocol, and reasons for prematurely terminating treat-
ment, will be recorded.
Interventions according to the classification system
Before providing any treatment, the PTs in this group
will be informed about the results of the classification
procedure. Patients will receive either direction-specific
exercises, spinal manipulation, or stabilisation.
I. Direction-specific exercises
Patients will perform exercises in the direction that
matches their directional preference: extension, flexion,
lateral (side-gliding right or left) or flexion-rotation
(right or left). For each direction is a treatment protocol
which contains patient-generated forces (sustained posi-
tions and/or repeated movements) and PT-generated
forces (mobilisations in the direction of preference). The
protocol can be adapted to the patient’s pain responses.
All patients will receive a booklet containing informa-
tion about directional preference and centralisation, the
exercises, and the correct performance and frequency of
each exercise. The patients will be instructed to perform
the exercises four times a day, to correct their posture
in the preferred direction, and to avoid activities and
positions that increase the intensity or peripheralisation
of symptoms. The patients will also be asked to keep an
exercise logbook to monitor their compliance.
II. Spinal manipulation
Patients will be treated with high velocity thrusts direc-
ted at the spinal levels from T12 to L5 and/or the
sacroiliac region. Decisions about the choice of the
technique (long lever to manipulate multiple levels or
short lever to manipulate one specific level) and the
location of the forces are left to the discretion of the
PTs. The most common spinal manipulation technique
in the Netherlands is one of the two technique options
in the Brennan et al. study [18], with the patient lying
on his/her side. The symptomatic side is manipulated
first. If the patient cannot specify a symptomatic side,
the PT can select a side. During each session, the PT
can make a maximum of four attempts (two on each
side) to achieve a cavitation (i.e. ‘a pop’) heard or felt by
the PT or the patient. Each session will end with 10
active flexion and extension movements of the lumbar
spine in a supine or quadruped position within the lim-
its of pain. The choice of this flexion-extension exercise
will be made by the PT. Patients will be instructed to
perform this active exercise once a day. The PT will
record the number of attempts, whether or not a cavita-
tion is heard or felt, and the technique that is used
(long or short lever). The PT is allowed to provide
spinal manipulation treatment for a maximum of 6
sessions.
III. Stabilisation
First, the patients will be taught to activate their local
stability system to control neutral joint position in a
supine position [29]. This (slight) co-activation of the
lumbar multifidus with the transversus abdominus
(’drawing in’ the stomach) must be accompanied by
minimal trunk movements and relaxation of global mus-
cles such as the upper abdominal muscles. The patients
will then be instructed to perform these abdominal bra-
cing exercises (’drawing in’ the stomach with normal
breathing) during strengthening exercises in standing,
quadruped, and side-support positions. Apart from these
standardised exercises, activity of the local and global
muscle systems will be trained in positions and move-
ments that aggravate the patient’s pain, in order to
restore functional capacity and to improve dynamic con-
trol. The patients will also receive an instruction book-
let, and will be instructed to perform the exercises once
a day and to keep self-monitoring exercise diaries.
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For all classification-based interventions, the treatment
frequency, amount and type of exercises, and the dura-
tion and progression of the programme will be recorded,
and directed by the judgment of the PT. The treatment
frequency will only be restricted for spinal manipulation
(maximum of 6 sessions). The patients will be treated
according to their primary classification for a minimum
of 4 weeks, during which the PT will be allowed to
change the treatment strategy, if (1) the functionality of
the patient improves significantly (a reduction of >30%
on the ODI, compared to the score at baseline) or (2)
the symptoms are severely aggravated. After the first
4 weeks, the PT will be allowed to provide follow-up
interventions. At the end of each patient’s treatment
period, the PT will note the degree of satisfaction with
the classification-based treatment, measured on a
5-point Likert scale ranging from very satisfied to very
dissatisfied.
In both treatment groups, the patients are requested
not to receive any co-interventions apart from the physi-
cal therapy (such as complementary and/or alternative
medicine [CAM]) during the intervention period. All
patients will be asked to stay active, and to engage in
general exercise activities (e.g. a sports club). The princi-
pal investigator will regularly monitor the PTs for com-
pliance with the treatment protocols, by means of visits,
phone calls and e-mail contact.
Blinding
The PTs will be asked not to disclose the treatment
allocation to the patients, and the success of the blind-
ing will be evaluated at the 8-week follow-up. The
research assistants and the participating statistician will
be blinded for the patient’s group assignment. The
research PTs and the treating PTs cannot be blinded for
the treatment allocation, but they will not be involved in
the outcome date-collection.
Measurements
The baseline questionnaire will include questions about
socio-demographic characteristics (e.g. age, gender, mar-
ital status, etc.) and all primary and secondary outcome
measures.
Primary outcome measures
Global perceived recovery will be measured by self-assess-
ment on a 7-point Likert scale ranging from “completely
recovered” to “worse than ever” [30]. This will be dichoto-
mised into success (complete and much recovered) and
non-success (slightly recovered, no change, slightly worse,
much worse and worse than ever). This measure has been
found to be useful in LBP research [31].
Functional status will be measured according to the
Dutch translation of the ODI, version 2.1a [32,33]. The
ODI is sub-divided into 10 sections related to activities
of daily living. Each section consists of 6 graded
responses, scored 0-5, and the total score can range
from 0 (no difficulty at all) to 50 (maximal difficulty).
The ODI is widely used in LBP studies, and has also
been used as a primary outcome measure in studies
focusing on the treatment-based classification approach
[12,18].
Pain intensity over the previous week will be mea-
sured on an 11-point numerical rating scale (0 = no
pain to 10 = worst imaginable pain), with reliability,
validity, and sensibility to change that are commonly
accepted in LBP research [34-36].
Secondary outcome measures
General health status will be evaluated with the Short
Form 36 (SF-36) [37]. It consists of 36 questions that
can be aggregated to form eight sub-scales (physical
functioning, mental health, general health perceptions,
pain, role limitations physical, role limitations emotional,
social functioning, and vitality) and two sum-scales
(physical and mental component scales). The scores on
all sub-scales range from 0-100, with higher scores indi-
cating better outcomes. It is a widely used measurement
instrument with satisfactory validity, reproducibility and
responsiveness to change [38], and the Dutch translation
has been found to be sufficiently valid [39].
Health-related quality of life will be measured with the
EuroQol (EQ-5D) [40]. This questionnaire assesses 5
dimensions (mobility, self-care, usual activities, pain/dis-
comfort and anxiety/depression) on a 3-point scale; no
problems, moderate problems and severe problems. The
questionnaire is appropriate for estimating quality-
adjusted life-years (QALYs), and can be used for cost-
utility analysis. The total score is expressed in utilities
according to the Dolan model [41]. The questionnaire
has been found to have adequate psychometric proper-
ties, and is commonly used in LBP research [42].
QALYs will be calculated by multiplying the utility of a
health state by the time spent in this health state, based
on the Dutch valuation tariff [43].
Fear-avoidance beliefs will be measured with the
Dutch version of the Fear-Avoidance Beliefs Question-
naire (FABQ) [44]. It consists of two multi-item scales,
measuring the patient’s beliefs about how physical activ-
ity (FABQPA, 5 questions) and work (FABQW, 11 ques-
tions) affect their LBP. Following the recommendations
of Waddell et al. [44], only 4 items will be included to
score the FABQPA sub-scale (range 0-24) and 7 items
to score the FABQW sub-scale (range 0-42). Higher
scores indicate more fear-avoidance beliefs.
Psychosocial status will be measured with the Örebro
Musculoskeletal Pain Screening Questionnaire
(ÖMPSQ) [45]. This questionnaire contains 25 items,
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divided into five groups (function, pain, psychological
factors, fear-avoidance, and miscellaneous), 21 of which
are scored on a 0-10 scale. The scores of the items are
summed to provide a total score range of 0-210, with
higher scores indicating a higher risk of a poor outcome.
The ÖMSPQ has been found to be a reliable and valid
predictor of outcome for patients with acute, subacute
and chronic LBP [46,47].
Work absenteeism and presenteeism will be measured
with the Productivity and Disease Questionnaire (PRO-
DISQ) [48]. This questionnaire was developed and vali-
dated in samples of patients and workers in the
Netherlands, and covers all relevant aspects of the rela-
tionship between health and productivity.
Direct and indirect costs will be measured by means
of self-completed cost diaries [49]. The following costs
will be evaluated: i) health care costs (e.g. primary care,
medical specialist care, prescription of medication, pro-
fessional home care and hospitalisation); ii) patient and
family costs (out-of-pocket expenses, such as over-the-
counter medication and the costs of paid and unpaid
help); and iii) costs of loss of productivity (work absen-
teeism and presenteeism, and costs due to days of inac-
tivity for patients without a paid job).
Table 1 presents an overview of the data-collection
procedures.
Sample size
Power calculations, based on the studies carried out by
Brennan et al. [18] and Fritz et al. [12], were performed
for the 3 main outcomes (for all: power 0.9; alpha 0.05).
To detect a clinically relevant mean difference between
the classification group and the usual care group of 9
points on the ODI (standard deviation [SD] 16), 55
patients are needed per group. To detect a clinically
relevant mean difference of 2 points (SD 2) for pain
(11-point numerical rating scale), 2 groups of 21
patients are needed. To detect a 20% difference in the
dichotomised global perceived recovery (recovered vs.
not recovered), 68 patients are needed per group.
Anticipating a potential drop-out of 10%, 75 participants
per treatment group (total n = 150) will be recruited.
Data-analysis
Baseline characteristics of the two intervention groups
with regard to the most important prognostic indicators
and main outcome measures will be compared to assess
the adequacy of the randomisation. If necessary, adjust-
ments will be made for baseline characteristics. The pri-
mary analysis will be an intention-to-treat analysis. A
per protocol analysis will be performed to estimate the
extent to which protocol deviations might have biased
the results. The data will be analysed in a linear mixed
model, with responses at 0 (baseline), 8, 26 and 52
weeks. In this model, the effect of interest is the time ×
treatment interaction. Estimates of treatment effects,
with 95% confidence intervals between baseline and fol-
low-up measurements, will be calculated and compared
between the two treatment groups. Multivariable regres-
sion analysis will be used to adjust for possible baseline
differences, and multilevel analysis will be performed,
with PT, patient, and time of measurement as levels.
Additionally, as a secondary analysis, a responder analy-
sis will be performed according to the cut-off values as
Table 1 Overview of the data-collection
Instrument Baseline 8 weeks 26 weeks 39 weeks 52 weeks
Demographic data X
Physical characteristics and primary classification X
Primary outcome
Global perceived recovery X X X
Disability (ODI) X X X X
Pain intensity (NRS) X X X X
Secondary outcome
General health (SF-36) X X X X
Health-related quality of life (EQ-5D) X X X X
Fear-avoidance beliefs (FABQ) X X
Psychosocial status (ÖMPSQ) X X
Economic evaluation
Costs (PRODISQ and cost diary) X X X X
Abbreviations: ODI = Oswestry Disability Index, NRS = Numerical Rating Scale, SF-36 = Short Form 36, EQ-5D = EuroQol, FABQ = Fear-Avoidance Beliefs
Questionnaire, ÖMPSQ = Örebro Musculoskeletal Pain Screening Questionnaire, PRODISQ = PROductivity and DISease Questionnaire
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proposed by a consensus panel [50]. If there are many
missing data, the missing data will be imputed with
multiple imputation techniques.
Economic evaluation from a societal perspective
The cost-effectiveness analysis will be carried out from a
societal perspective. The total back-pain-related costs for
patients in both intervention groups will be compared
with the health effects of the two groups, and cost-effec-
tiveness ratios will be calculated for the primary outcome
measures. The economic evaluation will be performed
according to the intention-to-treat principle. Costs will
be valued according to the guidelines published in the
updated handbook for economic evaluation in the Neth-
erlands [51]. The costs of production losses due to LBP
will be estimated for both paid and unpaid labour [52].
For paid labour, the costs will be calculated, using both
the human capital approach and the friction cost
approach. For unpaid labour, the indirect costs will be
estimated as the costs of production losses due to LBP,
e.g. voluntary work and household work, based on sha-
dow prices. The costs will be summed for each individual
patient, and bootstrapping will be used to make a pair-
wise comparison of the mean differences in total costs
between the two groups. Confidence intervals will be
obtained by bias-corrected and accelerated bootstrap-
ping, using 2000 replications [53].
Cost-utility and cost-effectiveness ratios will be esti-
mated, using bootstrapping techniques. The differences in
costs will be compared, and related to the differences in
effects (global perceived recovery, functional status and
pain intensity) and differences in QALYs. Bootstrapped
cost-effect pairs will be used to estimate cost-effectiveness
planes and cost-effectiveness acceptability curves. Cost-
effectiveness acceptability curves indicate the probability
that a treatment is cost-effective at a specific ceiling ratio,
which is the amount of money society is willing to pay to
gain one extra unit of effect. Sensitivity analysis will be
performed on the most important cost-drivers, in order to
assess the robustness of the results.
Discussion
There is an increasing interest in classification systems
for LBP patients that can be used to guide treatment.
One of the classification systems that has potentials to
improve the treatment decision-making process and
clinical outcomes is a classification system that was ori-
ginally proposed by Delitto et al. [8]. To critically exam-
ine and test the strength of this system, we designed an
RCT, together with an economic evaluation to investi-
gate whether treatment according to this system is more
cost-effective than usual care in reducing pain and
improving functioning in patients with subacute and
chronic LBP in primary care.
Contrast between interventions
In both intervention groups personalised, individually
tailored sessions will be given, and some of the same
examination and treatment techniques will be used.
However, some important features will account for the
contrast between the two groups. Patients in the classifi-
cation-based treatment group will be classified according
to a standardised examination protocol, and will be trea-
ted according to standardised treatment protocols. In
the usual care group however, the examination techni-
ques are expected to vary greatly among the PTs [54],
and the same examination findings can lead to a wide
range of treatment goals and strategies.
Modifications
The classification system is not a static system, and
some modifications have been made, based on new evi-
dence [25], and based on the context in which physical
therapy is provided within the Dutch health care system.
Patients with moderate complaints about one or more
items of the Urogenital Distress Inventory (UDI 6, short
form) will be excluded from the study. There are indica-
tions that patients with a combination of LBP and conti-
nence disorders require tailored treatment that is
partially beyond the scope of the classification system
[55]. The UDI 6 contains 6 questions on symptoms of
irritation, stress, and obstruction/discomfort [56].
Patients can indicate whether a symptom is present, and
if so, the degree to which it bothers them (not at all,
slightly, moderately or greatly). The UDI 6 is a widely
used, scientifically feasible questionnaire for urinary
incontinence evaluation purposes, and has been trans-
lated and validated in Dutch [57].
Previous studies, carried out by Fritz et al. [12] and
Brennan et al. [18], required that patients had at least a
moderate level of disability due to LBP. Fritz et al. [12]
required that patients had work restrictions, while Bren-
nan et al. [18] required that patients had an ODI score
>25%. In the present study, the level of disability is not
an inclusion criterion, and therefore the participants
may have less disability due to LBP than the participants
in previous studies.
In the original approach developed by Delitto et al. [8],
and in updated versions used by Fritz et al. [12] and
Brennan et al. [18], centralisation was considered as the
primary criterion for the classification of direction-speci-
fic exercises. In the present study however, directional
preference has been recognised and implemented as a
key examination finding for this classification [15,25].
Directional preference is a broader construct than centra-
lisation, and it is therefore expected that in the present
study more patients will be classified for direction-speci-
fic exercises than in previous studies, in which centralisa-
tion was the primary examination criterion [12,18].
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The criteria for manipulation classification have been
revised, based on the studies carried out by Flynn et al.
[11] and Childs et al. [14], and in the present study four
of these five criteria that they identified will be applied.
The criterion of a recent onset of symptoms (<16 days)
will be omitted in the present study, since the Dutch
guidelines for general practitioners [58] and the multi-
disciplinary guidelines [59] discourage PT in the acute
phase of LBP.
Patients who will be treated according to the manipu-
lation treatment protocol, will be treated with manipula-
tion techniques only, because recent research suggests
that these patients may only be responsive to manipula-
tion [11,14,60]. In previous studies, patients in this sub-
group could also be treated with mobilisation
techniques [12,18]. There is no current evidence for the
supremacy of one single manipulation technique [25], so
the choice of the manipulation technique will be left to
the discretion of the PTs.
No patients in the present study will be classified in
the traction subgroup. Although this subgroup is likely
to be quite small [19], the exclusion of this treatment
may influence the effectiveness of the approach.
Finally, the classification system, which was originally
developed for patients with acute low back pain [8], has
undergone some validation studies for patients with sub-
acute and chronic LBP [14,15,18,20]. Researchers have
suggested that it is more appropriate to subgroup and
treat patients with chronic LBP according to psychoso-
cial symptoms instead of the biomechanical signs and
symptoms used in the classification system [61,62].
However, although it is well recognised that some key
psychosocial factors are overall predictors of outcome
[63], there is limited and controversial evidence that
these factors can indicate a specific type of treatment
[64]. This study will make it possible to investigate the
usefulness of the classification system for patients with
more chronic LBP symptoms.
The results of this trial will be available in November
2010.
Additional file 1: Table S1.Treatment-based classification studies. It
contains relevant publications of the treatment-based classification
system that we are investigating.
Additional file 2: Operational definitions for the physical
measurements (= Appendix). It contains the tests that we will use to
classify the patients.
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